Pharmacologic approaches to musculoskeletal disorders

Clinics in Geriatric Medicine

Volumn 4, Issue 2, 1988, Pages 441-461

  Roth, S H ^a  

^a Arthritis Center Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; AURANOFIN; AZATHIOPRINE; BUPRENORPHINE; BUTORPHANOL; CODEINE; CORTICOSTEROID; DEXTROPROPOXYPHENE; DIHYDROMORPHINE; GOLD SALT; LEVORPHANOL; METHADONE; METHOTREXATE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PENICILLAMINE; PENTAZOCINE; PETHIDINE; SALICYLIC ACID;

AGE; AGED; ANALGESIA; GASTROINTESTINAL TOXICITY; HUMAN; MUSCULOSKELETAL DISEASE; NEPHROTOXICITY; SHORT SURVEY;

EID: 0024216696     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0749-0690(18)30758-4     Document Type: Review

References (100)

1. April PA, Curran NJ, Ekholm BP, et al: Multicenter comparative study of salsalate (SSA) vs aspirin (ASA) in rheumatoid arthritis (Abstr). Slst American Rheumatism Association meeting, Washington, DC, 1987
2. Bender A.D. Effect of age on intestinal absorption J Am Geriatr Soc 16 1968 1331
3. Benjamin S.B. Ishak K.G. Zimmerman H.J. Phenylbutazone liver injury: A clinical-pathologic survey of 23 cases and review of the literature Hepatology 1 1981 255
4. Berg K.J. Talseth T. Acute renal effects of sulindac and indomethacin in chronic renal failure Clin Pharmacol Ther 37 1985 447
5. Berkowitz J.M. Adler S.N. Sharp J.T. Reduction of aspirin-induced gastroduodenal mucosal damage with ranitidine J Clin Gastroenterol 8 1986 377
6. Blackshear J.L. Napier J.S. Davidman M. Renal complications of nonsteroidal anti-inflammatory drugs: Identification and monitoring of those at risk Semin Arthritis Rheum 14 1985 163
7. Bloomfield S.S. Analgesic agents Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 301
8. Bollet A.J. Piroxicam serum levels in patients treated for rheumatic diseases Semin Arthritis Rheum 14 1 1985 25
9. Borsch G. Schmidt G. What’s new in steroid and nonsteroid drug effects on gastroduodenal mucosa Pathol Res Pract 180 1985 437
10. Briant R.H. Dorrington R.E. Cleal J. The rate of acetaminophen metabolism in the elderly and the young J Am Geriatr Soc 24 1976 359
11. Brindley D. Roth S.H. East L. Endoscopy controlled study of the safety of nabumetone versus naproxen in arthritis therapy. Xlth European Congress of Rheumatology meeting 1987 Greece Athens
12. Byron M.A. Mowat A.G. Corticosteroid prescribing in rheumatoid arthritis—The fiction and the fact Br J Rheumatol 24 1985 164
13. Christophidis N. Methotrexate Clin Rheum Dis 10 1984 401
14. Ciabattoni G. Pugliese F. Cinotti G.A. Renal effects of anti-inflammatory drugs Eur J Rheumatol Inflamm 3 1980 210
15. Collier D.S. Pain J.A. Nonsteroidal anti-inflammatory drugs and peptic ulcer perforation Gut 26 1985 359
16. Conn H.O. Blitzer B.L. Nonassociation of adenocorticosteroid therapy and peptic ulcer N Engl J Med 294 1976 473
17. Curt G.A. Kaldany A. Whitley L.G. Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calcium Ann Intern Med 92 1980 72
18. Denham M.J. Prescribing for the elderly patient S Afr Med J 62 1982 405
19. Dunn M. The role of arachidonic acid metabolites in renal homeostatis: Nonsteroidal anti-inflammatory drugs renal function in biochemical, histological and clinical effects Drugs 33 1987 56
20. Dykman T.R. Gluck O.S. Murphy W.A. Evaluation of factors associated with gluco-corticoid-induced osteopenia in patients with rheumatic diseases Arthritis Rheum 28 1985 361
21. Fries JF: The at-risk gastropathy population: Recognition and responses. “Perspectives on Gastropathy and Arthritis Therapy” symposium, 5lst American Rheumatism Association meeting, Washington, DC, 1987
22. Goodman G.A. Goodman L.S. Gilman A. The Pharmacological Basis of Therapeutics. Edition 6 1980 Macmillan New York
23. Gottlieb N.L. Auranofin Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 442
24. Harris E.D. Jr Emkey R.D. Nichols J.E. Low dose prednisone therapy in rheumatoid arthritis: A double blind study J Rheumatol 10 1983 713
25. Harter JG: FDA, anti-rheumatic drugs and you. Drug Study group presentation at the 5lst American Rheumatism Association meeting, Washington, DC, 1987
26. Hench P.S. Kendall E.C. Slocumb C.H. The effect of a hormone of the adrenal cortex (17-hydroxy-ll-dehydrocorticosterone; compound E) and of pituitary adrenocorti-cotrophic hormone on rheumatoid arthritis Mayo Clin Proc 24 1949 181
27. Hollander D. Sucralfate: A new agent for treatment of duodenal ulcer. In Caspary WF (ed): “Duodenal Ulcer, Gastric Ulcer: Sucralfate, A New Therapeutic Concept,” Sucralfate Symposium, Proceedings of the 11th International Congress of Gastroenterology, Hamburg, GDR, 1980 1981 Munich Urban and Schwarzenberg 45
28. Inman W.H. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone Br Med J [Clin Res] 1 1977 1500
29. Jaffe I.A. Penicillamine Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 367
30. Kato R. Vassanelli P. Frontino G. Variation in the activity of liver microsomal drug metabolizing enzymes in relation to age Biochem Pharmacol 13 1964 1037
31. Kean W.F. Buchanan W.W. Antirheumatic drug therapy in the elderly: A case of failure to identify the correst issues? J Am Geriatr Soc 35 1987 363
32. Kean W.F. Bellamy N. Brooks P.M. Gold therapy in the elderly rheumatoid arthritis patient Arthritis Rheum 26 1983 705
33. Kean W.F. Buchanan W.W. Drug therapy in the elderly Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 457
34. Kinlen L.J. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment Am J Med 78 1A 1985 44
35. Lasagna L. Drug effects as modified by aging J Chronic Dis 3 1956 567
36. Leobl D.H. Craig R.M. Culic D.D. Gastrointestinal blood loss: Effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers JAMA 237 1977 976
37. Lewis G.P. Jusko W.J. Burke C.W. Boston Collaborative Drug Surveillance Program: Prednisone side effects and serum protein levels. A collaborative study Lancet 2 1971 778
38. Liebling M.R. Lieb E. McLaughlin K. Pulse methyl prednisolone in rheumatoid arthritis Ann Intern Med 94 1981 21
39. Lorber A. Gold salt therapy Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 415
40. Mackenzie A.H. Antimalarial drug therapy Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 353
41. Marks I.N. Lucke W. Wright J.P. Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate J Clin Gastroenterol 3 1981 163
42. McBay A.J. Propoxyphene overdose deaths JAMA 233 1975 1257
43. McHardy G. Ulcer disease in the elderly. Cytoprotection: Proceedings of a Symposium 1985 Biomedical Information New York 10
44. Mitchell D.M. Spitz P.W. Young D.L. Survival, prognosis, and causes of death in rheumatoid arthritis Arthritis Rheum 29 1986 706
45. Mitchell J.R. Horning M.G. Drug metabolism and drug toxicity 1984 Raven Press New York
46. Moezzi B. Fatourechi V. Khozain R. The effect of penicillamine on serum digoxin levels Jpn Heart J 19 1978 366
47. Mongan E. Kelly P. Nies K. Tinnitus as an indication of therapeutic serum salicylate levels JAMA 226 1973 142
48. Morris H.G. Sherman N.A. McQuain C. Effects of salsalate (non-acetylated salicylate) and aspirin on serum prostaglandins in humans Ther Drug Monit 7 1985 435
49. Nagashima R. Mechanisms of actions of sucralfate J Clin Gastroenterol 3 2 1981 117
50. Nanra R.S. Renal effects of antipyretic analgesics Am J Med 75 1983 70
51. Needs C.J. Brooks R.M. Clinical pharmacokinetics of the salicylates Clin Pharmacokinet 10 1985 164
52. Neustadt D.H. Corticosteroids Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 397
53. Novak L.P. Aging, total body potassium, fat free mass, and cell mass in males and females between the ages of 18 and 35 years J Gerontol 27 1972 438
54. Nyfors A. Methotrexate therapy of psoriasis: Effect and side effects with particular reference to hepatic changes: A survey Danish Med Bull 27 1980 74
55. O’Malley K. Laher M. Cusack B. Clinical pharmacology and the elderly patient Denham M.J. Treatment in Medical Problems in the Elderly 1980 University Park Press Baltimore 7
56. O’Malley K. Crooks J. Dukes E. Effect of age and sex of human drug metabolism Br Med J [Clin Res] 607 1971
57. Otten AL: Even more Americans live into 80’s and 90’s causing big problems: The strain on social services and relatives will rise; should care be rationed? Wall Street journal, 7/30/87
58. Paulus H.E. Government affairs: FDA arthritis advisory committee meeting Arthritis Rheum 25 1982 1124
59. Prescott L.F. Critchley J.A.J.H. Drug interactions affecting analgesic toxicity Am J Med 75 1983 113
60. Reidenberg M.M. Renal function and drug action 1971 WB Saunders Philadelphia
61. Restivo C. Paulus H.E. Anaphylaxis from tolmetin JAMA 240 1978 246
62. Richardson C.J. Blocka K.L.N. Ross S.G. Effects of age and sex on piroxicam disposition Clin Pharmacol Ther 37 1985 13
63. Robert A. Cytoprotection by prostaglandins Gastroenterology 77 1979 761
64. Rossi A.C. Knapp D.E. Tolmetin-induced anaphylactoid reactions N Engl J Med 307 1982 449
65. Roth S.H. Mackenzie A. Drug development, guidelines, and the Food and Drug Administration (Editorial) Ann Intern Med 101 1984 125
66. Roth S.H. Analgesics: Secondary supplements. In New Directions in Arthritis Therapy 1980 PSG Publishing Littleton, MA 37
67. Roth S.H. Bennett R.E. Nonsteroidal anti-inflammatory drug gastropathy: Recognition and response Arch Intern Med 147 1987 2093
68. Roth SH: FDA, anti-rheumatic drugs and you. Drug Study Group presentation at the 5lst American Rheumatism Association meeting, Washington, DC, 1987
69. Roth S.H. Salicylates: Revolution versus evolution. New Directions in Arthritis Therapy 1980 PSG Publishing Littleton, MA 23
70. Roth S.H. Salicylates Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 309
71. Roth S.H. Nonsteroidal anti-inflammatory drug gastropathy. We started it—can we stop it? (Editorial) Arch Intern Med 146 1986 1075
72. Roth SH: Salicylates. In Katz WA (ed): Management of Rheumatic Disease. Edition 2. Philadelphia, JB Lippincott (in press)
73. Roth SH, Agrawal N, Mahowald M, et al: Misoprostol heals aspirin-induced gastropathy in rheumatoid arthritis (Abstr). 5lst American Rheumatism Association meeting, Washington, DC, 1987
74. Roth SH: Databank comparison of single versus combined anti-inflammatory drug therapy in arthritis. Presented at the 15th International Congress of Rheumatology, Paris, France, 1981
75. Roth S.H. Steps to understanding drug use in rheumatology Roth S.H. Handbook of Drug Therapy in Rheumatology 1985 PSG Publishing Littleton, MA 181
76. Roth S.H. The new look in drugs: Is “longer lasting” better? (Editorial) Arch Intern Med 144 1984 472
77. Roth S.H. Booth G. An open trial of naproxen in rheumatoid arthritis patients with significant esophageal, gastric and duodenal lesions J Clin Pharm 15 1974 378
78. Roth SH: Endoscopic comparison of the tolerance and safety of carprofen and ibuprofen in patients with rheumatoid arthritis (Abstract). IX Pan American Congress of Rheumatology meeting, Buenos Aires, Argentina, 1986
79. Roth S.H. Introduction to NSAIDs: Chaos to confusion. In New Directions in Arthritis Therapy 1980 PSG Publishing Littleton, MA 53
80. Roth S.H. Bennett R.E. Mitchell C.S. Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy: Double-blind long term evaluation Arch Intern Med 147 1987 1798
81. Roth S.H. Corticosteroid therapy. In New Directions in Arthritis Therapy 1980 PSG Publishing Littleton, MA 43
82. Rotstein J. Good R.A. Steroid pseudorheumatism Arch Intern Med 99 1957 545
83. Rumack B.H. Acetaminophen overdose Am J Med 5 1983 104
84. Russel G.I. Bing R.F. Walls J. Interstitial nephritis in a case of phenylbutazone hypersensitivity Br Med J [Clin Res] 1 1978 1322
85. Russell A.S. Sturge R.A. Smith M.A. Serum transaminases during salicylate therapy Br Med J [Clin Res] 2 1971 428
86. Sedor J.R. Williams S.L. Chremos A.N. Effects of sulindac and indomethacin on renal prostaglandin synthesis Clin Pharmacol Ther 36 1984 85
87. Shea-Donohue T. Steel L. Montcalm E. Gastric protection by sucralfate. Role of mucus and prostaglandins Gastroenterology 91 1986 660
88. Sheon R.P. Nonarticular rheumatism and nerve entrapment syndromes Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 135
89. Silverstein F.E. Feld A.D. Gilbert D.A. Upper gastrointestinal tract bleeding. Predisposing factors, diagnosis and therapy Arch Intern Med 141 1981 322
90. Silvoso G.R. Ivey K.J. Butt J.H. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy Ann Intern Med 91 1979 517
91. Swift C.G. Homeida M. Holliwell M. Antipyrine disposition and liver size in the elderly Eur J Clin Pharmacol 14 1978 149
92. Taggert H.M. Alderdice J.M. Fatal cholestatic jaundice in elderly patients taking benoxa-profen Br Med J [Clin Res] 284 1982 1372
93. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs Nature New Biol 231 1971 232
94. Vane J.R. The evolution of non-steroidal anti-inflammatory drugs and their mechanism of action Drugs 33 1987 18
95. Walt R. Katschinski B. Logan R. Rising frequency of ulcer perforation in elderly people in the United Kingdom Lancet 1 1986 489
96. Ward J.R. Nonsteroidal (nonsalicylate) anti-inflammatory drugs Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 367
97. Wilkens R.F. Immunomodulating agents Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 324
98. Wilske K.R. Polymyalgia rheumatica and giant cell (temporal) arteritis Roth S.H. Rheumatic Therapeutics 1985 McGraw Hill New York 207
99. Wolfe F. Kleinheksel S.M. Spitz P.E. A multicenter study of hospitalization in Arheumatoid arthritis: Frequency, medical-surgical admission, and charges Arthritis Rheum 29 1986 614
100. Woolf A.D. Rogers H.J. Bradook I.D. Pharmacokinetic observations on piroxicam in young adults, middle aged and elderly patients Br J Clin Pharm 16 1983 433